Stock Price
394.84
Daily Change
-5.68 -1.42%
Monthly
31.43%
Yearly
13.23%
Q3 Forecast
397.20

United Therapeutics reported $527.1M in Current Liabilities for its fiscal quarter ending in June of 2025.




Current Liabilities Change Date
Amarin USD 162.41M 17.54M Mar/2025
Ardelyx USD 81.72M 3.89M Jun/2025
Baxter International USD 3.48B 3.03B Mar/2025
Bayer EUR 29.78B 1.82B Jun/2025
Biogen USD 3.18B 2.11B Jun/2025
BioMarin Pharmaceutical USD 684.25M 56.03M Jun/2025
Gilead Sciences USD 11.19B 1.15B Jun/2025
GlaxoSmithKline GBP 20.38B 453M Jun/2025
Halozyme Therapeutics USD 134.28M 16.1M Jun/2025
Insmed USD 311.68M 72.45M Jun/2025
Ionis Pharmaceuticals USD 897.24M 646.94M Jun/2025
J&J USD 56.9B 6.58B Mar/2025
Moderna USD 1.57B 32M Jun/2025
Pfizer USD 37.73B 1.27B Jun/2025
PTC Therapeutics USD 627.81M 32.42M Jun/2025
Regeneron Pharmaceuticals USD 3.67B 100.4M Jun/2025
Sarepta Therapeutics USD 919.95M 314.36M Jun/2025
Teva Pharmaceutical Industries USD 11.86B 704M Jun/2025
United Therapeutics USD 527.1M 194.4M Jun/2025
Vertex Pharmaceuticals USD 4.14B 355.2M Jun/2025